ストックスクリーナーアプリを入手
3.2293
16.05%
0.4693
前日終値:
$2.76
開ける：
$3
24時間の取引高:
251.19K
Relative Volume:
0.15
時価総額：
$36.72M
収益：
$128.60K
当期純損益:
$-4.60M
株価収益率:
-9.2266
EPS:
-0.35
ネットキャッシュフロー:
$-3.74M
1週間 パフォーマンス:
+11.22%
1か月 パフォーマンス:
-21.97%
6か月 パフォーマンス:
+112.13%
1年 パフォーマンス:
+704.19%
1日の値動き範囲:
$3.00
$3.25
1週間の範囲:
$2.52
$3.25
52週間の値動き範囲:
$0.2528
$4.4899
Nexalin Technology Inc Stock (NXL) Company Profile
NXL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NXL
Nexalin Technology Inc
|
3.2297 | 36.72M | 128.60K | -4.60M | -3.74M | -0.63 |
|
ABT
Abbott Laboratories
|
113.35 | 196.18B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
361.46 | 137.26B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
89.87 | 131.64B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
80.36 | 102.43B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
72.68 | 43.66B | 6.60B | 4.16B | 490.10M | 6.93 |
Nexalin Technology Inc (NXL) 最新ニュース
Certain Common Stock of Nexalin Technology, Inc. are subject to a Lock-Up Agreement Ending on 2-JAN-2025. - Marketscreener.com
Nexalin Technology (NASDAQ:NXL) Shares Up 5.5% – Here’s What Happened - Defense World
How Do Things Look For Nexalin Technology Inc (NASDAQ: NXL) In The Short-Term? - Stocks Register
Nexalin Technology, Inc. Launches Phase 1 of AI-Driven Virtual Clinic to Enhance Mental Health Treatment - Nasdaq
Nexalin Technology Completes Phase 1of its Innovative Virtual Clinic - GlobeNewswire
Nexalin Technology, Inc. Completes Phase 1 of Its Innovative Virtual Clinic - Marketscreener.com
Target Corp (TGT-N) QuotePress Release - The Globe and Mail
Walmart Inc (WMT-N) QuotePress Release - The Globe and Mail
Maxim Group Reaffirms Hold Rating for Nexalin Technology (NASDAQ:NXL) - Defense World
Nexalin Technology’s Strong Financial Position: No Defaults on Senior Securities - MSN
Nexalin Technology downgraded to Hold from Buy at Maxim - MSN
Maxim Group Downgrades Nexalin Technology (NXL) - MSN
Nexalin Technology Stock Soars to All-Time High of $4.4 Amidst Stunning Growth - Investing.com Canada
Nexalin Technology (NASDAQ:NXL) and ENDRA Life Sciences (NASDAQ:NDRA) Head-To-Head Survey - Defense World
Nexalin Technology, Inc. (NASDAQ:NXL) Short Interest Update - MarketBeat
New Peer-Reviewed Publication Validates Nexalin’s Deep Intracranial Frequency Stimulation (DIFS) Technology, Reinforcing Leadership in High-Growth Neuromodulation Market - Marketscreener.com
Nexalin Technology announces peer-reviewed publication on DIFS technology - Nasdaq
New Peer-Reviewed Publication Validates Nexalin’s Deep - GlobeNewswire
Nexalin's Brain Stimulation Tech Breakthrough Validated in Major Medical Journal | NXL Stock News - StockTitan
Alibaba Group Holding ADR (BABA-N) QuotePress Release - The Globe and Mail
Nexalin Technology stock soars to all-time high of $4.07 - Investing.com
Nexalin Technology stock soars to all-time high of $4.07 By Investing.com - Investing.com UK
Nexalin Technology CEO Provides Letter to Shareholders - GlobeNewswire
Nexalin's Breakthrough: Alzheimer's Studies Show Promise, Secures Key Brain Tech Patent | NXL Stock News - StockTitan
Is Nexalin Technology (NASDAQ:NXL) In A Good Position To Invest In Growth? - Yahoo Finance
Nexalin Technology Inc (NXL) Quarterly 10-Q Report - Quartzy
Nexalin regains Nasdaq compliance with bid price rule By Investing.com - Investing.com Australia
Nexalin regains Nasdaq compliance with bid price rule - Investing.com India
Join Nexalin Technology's Exclusive Live Investor Webinar and Q&A Session on November 5th - The Manila Times
Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on November 5th - GlobeNewswire
Nexalin Technology : Regains Compliance with Nasdaq Continued Listing Requirements Form 8 K - Marketscreener.com
Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements - The Manila Times
LOBO EV and Nexalin Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - AccessWire
Nexalin technology's chief medical officer buys $1,095 in stock By Investing.com - Investing.com Canada
Nexalin technology's chief medical officer buys $1,095 in stock - Investing.com India
Significant Stock Increase For Nexalin (NXL) After Alzheimer’s Study Announcement - Stocks Telegraph
EXCLUSIVE: Nexalin Technology Says New Data Confirms Implantable Device Improves Cognitive Function, Restores Brain Activity in Alzheimer's Patients - AOL
Nexalin Technology Announces Landmark Study on Alzheimer's Disease and Deep Intracranial Frequency Stimulation Published in Journal of Alzheimer's Disease - The Manila Times
Nexalin Technology Announces Landmark Study on Alzheimer's - GlobeNewswire
EXCLUSIVE: Nexalin Technology Says New Data Confirms Investigational Non-Invasive Neurostimulation Device Improves Cognitive Function, Restores Brain Activity in Alzheimer's Patients (UPDATED) - Benzinga
Nexalin Technology and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - AccessWire
Nexalin Technology Inc (NXL) 財務データ
収益
当期純利益
現金流量
EPS
Nexalin Technology Inc (NXL) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Owens David | Chief Medical Officer |
Aug 13 '24 |
Buy |
0.95 |
1,000 |
950 |
147,793 |
| Owens David | Chief Medical Officer |
Jun 28 '24 |
Buy |
1.75 |
1,000 |
1,750 |
146,793 |
| Owens David | Chief Medical Officer |
Jun 18 '24 |
Buy |
0.71 |
1,619 |
1,149 |
145,793 |
| Owens David | Chief Medical Officer |
Jun 10 '24 |
Buy |
0.64 |
3,000 |
1,920 |
144,174 |
0.30%
0.04%
大文字化:
|
ボリューム (24 時間):